Evidence map›Paper›PMID 27558639›Full record

ArticleMolecular & cellular proteomics : MCP2016

Cysteine S-linked N-acetylglucosamine (S-GlcNAcylation), A New Post-translational Modification in Mammals.

Jason C Maynard, Alma L Burlingame, Katalin F Medzihradszky

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Characterization of a novel glycocin from a thermophile.bioRxiv : the preprint server for biology · 2025
    Article
  3. Characterization of S-glycosylated glycocins containing three disulfides.Journal of industrial microbiology & biotechnology · 2024
    Article
  4. Ultradeep O-GlcNAc proteomics reveals widespread O-GlcNAcylation on tyrosine residues of proteins.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Structure and Function of TET Enzymes.Advances in experimental medicine and biology · 2022
    Article
  13. Writing and erasing O-GlcNAc from target proteins in cells.Biochemical Society transactions · 2021
    Article
  14. Article
  15. The glycosylation in SARS-CoV-2 and its receptor ACE2.Signal transduction and targeted therapy · 2021
    Review
  16. Advances in chemical probing of proteinChemical Society reviews · 2021
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jason C MaynardFrom the ‡Department of Pharmaceutical Chemistry, School of Pharmacy, University of California San Francisco, 600 16th Street Genentech Hall, N472, Box 2240, San Francisco, California 94158-2517.
Alma L BurlingameFrom the ‡Department of Pharmaceutical Chemistry, School of Pharmacy, University of California San Francisco, 600 16th Street Genentech Hall, N472, Box 2240, San Francisco, California 94158-2517.
Katalin F MedzihradszkyFrom the ‡Department of Pharmaceutical Chemistry, School of Pharmacy, University of California San Francisco, 600 16th Street Genentech Hall, N472, Box 2240, San Francisco, California 94158-2517 folkl@cgl.ucsf.edu.
University of California, San Francisco · US

Funding

Bio-Organic Biomedical Mass Spectromy ResourceP41GM103481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURLINGAME, ALMA L · 2012 to 2015
$6.4M
Howard Hughes Medical InstituteNIGMS NIH HHS P41 GM103481
6 · The paper itself

Abstract

Intracellular GlcNAcylation of Ser and Thr residues is a well-known and widely investigated post-translational modification. This post-translational modification has been shown to play a significant role in cell signaling and in many regulatory processes within cells. O-GlcNAc transferase is the enzyme responsible for glycosylating cytosolic and nuclear proteins with a single GlcNAc residue on Ser and Thr side-chains. Here we report that the same enzyme may also be responsible for S-GlcNAcylation, i.e. for linking the GlcNAc unit to the peptide by modifying a cysteine side-chain. We also report that O-GlcNAcase, the enzyme responsible for removal of O-GlcNAcylation does not appear to remove the S-linked sugar. Such Cys modifications have been detected and identified in mouse and rat samples. This work has established the occurrence of 14 modification sites assigned to 11 proteins unambiguously. We have also identified S-GlcNAcylation from human Host Cell Factor 1 isolated from HEK-cells. Although these site assignments are primarily based on electron-transfer dissociation mass spectra, we also report that S-linked GlcNAc is more stable under collisional activation than O-linked GlcNAc derivatives.

Indexed as

AcetylglucosamineAnimalsCysteineGlycopeptidesHEK293 CellsHost Cell Factor C1HumansMass SpectrometryMiceN-AcetylglucosaminyltransferasesProtein Processing, Post-TranslationalRatsAcetylglucosamineCysteineGlycopeptidesHCFC1 protein, humanHost Cell Factor C1N-AcetylglucosaminyltransferasesO-GlcNAc transferase

Identifiers

PMID27558639
PMCPMC5098038
OpenAlexW2512633185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.